# Cluster2-13 Analysis

## Proteins: 

ABRAXAS1, ACD, C11orf54, C16orf87, CBX1, CENPB, CENPT, CLUH, CNOT7, COMMD3-BMI1, DCLRE1B, DHX35, DPYSL5, DTWD2, EEFSEC, ERCC1, ERCC4, FGF2, FZD2, GON4L, GTF2B, HES6, HMBOX1, INTS7, LRRC41, LYRM4, MED11, MED19, MED7, NBR1, NCOA2, NEUROG1, NFATC1, NHLH2, NOP10, NUFIP2, PML, PMS1, PPWD1, RAD18, RAD51B, RNF2, RP2, SBF1, SH3BGRL3, SH3BP5, STK4, TERF2, TERF2IP, TINF2, TP53BP1, TSC22D1, TSEN54, UIMC1, ZWINT

### Telomere Maintenance and DNA Repair Protein System

**Summary**

The human protein system analyzed in this report comprises proteins involved in telomere maintenance, DNA repair, and transcription regulation. The system includes 46 proteins with protein binding function, 35 proteins localized in the nucleoplasm, and 34 proteins in the nucleus. The proteins in this system are involved in various cellular processes, such as DNA binding, transcription regulation, and chromatin organization. Notably, the shelterin complex, which plays a crucial role in telomere maintenance, is represented by four proteins: ACD, TERF2, TERF2IP, and TINF2. Additionally, proteins such as ERCC1 and ERCC4 are involved in nucleotide-excision repair, while RAD18 and RAD51B participate in DNA repair and double-strand break repair via homologous recombination. The system also includes proteins involved in transcription regulation, such as HES6, NEUROG1, NFATC1, and NHLH2. Given the cellular location and function of the proteins in this system, we propose the name "Telomere Maintenance and DNA Repair Protein System."

**References**

1. Palm, W., & de Lange, T. (2008). How shelterin protects mammalian telomeres. Annual Review of Genetics, 42, 301-334. [DOI: 10.1146/annurev.genet.41.110306.130350](https://doi.org/10.1146/annurev.genet.41.110306.130350)

2. Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry, 73, 39-85. [DOI: 10.1146/annurev.biochem.73.011303.073723](https://doi.org/10.1146/annurev.biochem.73.011303.073723)

3. Kornberg, R. D. (2007). The molecular basis of eukaryotic transcription. Proceedings of the National Academy of Sciences, 104(32), 12955-12961. [DOI: 10.1073/pnas.0704138104](https://doi.org/10.1073/pnas.0704138104)

4. O'Sullivan, R. J., & Karlseder, J. (2010). Telomeres: protecting chromosomes against genome instability. Nature Reviews Molecular Cell Biology, 11(3), 171-181. [DOI: 10.1038/nrm2848](https://doi.org/10.1038/nrm2848)

5. Ciccia, A., & Elledge, S. J. (2010). The DNA damage response: making it safe to play with knives. Molecular Cell, 40(2), 179-204. [DOI: 10.1016/j.molcel.2010.09.019](https://doi.org/10.1016/j.molcel.2010.09.019)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 46 | FZD2, ERCC1, C16orf87, ABRAXAS1, ACD, C11orf54, CBX1, CENPT, CNOT7, DCLRE1B, DPYSL5, ERCC4, FGF2, GTF2B, HES6, HMBOX1, INTS7, LRRC41, LYRM4, MED11, MED19, MED7, NBR1, NCOA2, NEUROG1, NFATC1, NHLH2, NOP10, NUFIP2, PML, PMS1, RAD18, RAD51B, RNF2, RP2, SH3BGRL3, SH3BP5, STK4, TERF2, TERF2IP, TINF2, TP53BP1, TSC22D1, TSEN54, UIMC1, ZWINT |
| nucleoplasm | 35 | ERCC1, ABRAXAS1, ACD, C11orf54, CBX1, CENPB, CENPT, DCLRE1B, DHX35, ERCC4, GON4L, GTF2B, HMBOX1, INTS7, MED7, NBR1, NCOA2, NFATC1, NOP10, NUFIP2, PML, PPWD1, RAD18, RAD51B, RNF2, RP2, SH3BP5, STK4, TERF2, TERF2IP, TINF2, TP53BP1, TSEN54, UIMC1, ZWINT |
| nucleus | 34 | ABRAXAS1, C11orf54, CBX1, CENPB, CNOT7, DTWD2, EEFSEC, ERCC4, FGF2, GON4L, GTF2B, HES6, HMBOX1, INTS7, LRRC41, MED11, MED19, MED7, NCOA2, NEUROG1, NFATC1, NHLH2, NUFIP2, PML, PMS1, RAD18, RAD51B, RNF2, STK4, TERF2, TERF2IP, TP53BP1, TSC22D1, UIMC1 |
| nuclear body | 33 | ABRAXAS1, ACD, C11orf54, CBX1, CENPB, CENPT, CNOT7, DCLRE1B, GON4L, GTF2B, HMBOX1, INTS7, LYRM4, MED7, NBR1, NCOA2, NFATC1, NOP10, NUFIP2, PPWD1, RAD18, RNF2, RP2, SBF1, SH3BGRL3, SH3BP5, STK4, TERF2, TERF2IP, TINF2, TP53BP1, UIMC1, ZWINT |
| cytoplasm | 25 | FZD2, ERCC1, CLUH, CNOT7, DCLRE1B, DTWD2, EEFSEC, FGF2, HMBOX1, INTS7, LRRC41, NCOA2, NFATC1, NUFIP2, PML, RAD18, RNF2, RP2, SBF1, SH3BGRL3, SH3BP5, STK4, TERF2IP, TP53BP1, ZWINT |
| cytosol | 14 | CENPT, CNOT7, DPYSL5, HMBOX1, LRRC41, NBR1, NFATC1, NUFIP2, PML, SBF1, SH3BGRL3, STK4, TSC22D1, ZWINT |
| chromosome, telomeric region | 11 | ERCC1, ACD, CBX1, DCLRE1B, ERCC4, HMBOX1, PML, TERF2, TERF2IP, TINF2, TP53BP1 |
|  transcription by RNA polymerase II | 11 | CNOT7, FGF2, HES6, MED19, MED7, NCOA2, NEUROG1, NFATC1, NHLH2, TP53BP1, TSC22D1 |
|  DNA-templated transcription | 10 | FZD2, FGF2, GON4L, HES6, HMBOX1, NCOA2, NFATC1, PML, TERF2IP, TP53BP1 |
| DNA binding | 10 | ERCC1, CBX1, CENPB, CENPT, ERCC4, PML, PMS1, RAD51B, TINF2, UIMC1 |
| identical protein binding | 7 | CBX1, ERCC4, FGF2, HMBOX1, LRRC41, RAD18, STK4 |
| chromatin | 7 | CBX1, HES6, HMBOX1, NCOA2, NEUROG1, NFATC1, NHLH2 |
| telomeric DNA binding | 6 | ACD, HMBOX1, TERF2, TERF2IP, TINF2, TP53BP1 |
| protein homodimerization activity | 6 | DCLRE1B, LYRM4, NEUROG1, PML, STK4, TERF2 |
| damaged DNA binding | 5 | ERCC1, DCLRE1B, ERCC4, RAD18, TP53BP1 |
| protein-containing complex binding | 5 | ACD, DCLRE1B, HMBOX1, RAD18, TERF2 |
| telomere maintenance | 5 | ACD, DCLRE1B, ERCC4, TERF2, TERF2IP |
| telomere capping | 5 | ACD, DCLRE1B, TERF2, TERF2IP, TINF2 |
|  telomere maintenance | 5 | ACD, PML, TERF2, TERF2IP, TINF2 |
| zinc ion binding | 5 | C11orf54, GTF2B, NBR1, PML, RNF2 |
| chromatin binding | 5 | CBX1, CENPB, NCOA2, NEUROG1, RNF2 |
| negative regulation of transcription by RNA polymerase II | 5 | CBX1, HES6, HMBOX1, NCOA2, RNF2 |
| membrane | 5 | CNOT7, LRRC41, NBR1, NUFIP2, SBF1 |
| RNA polymerase II-specific DNA-binding transcription factor binding | 5 | HES6, NFATC1, NHLH2, STK4, TP53BP1 |
| sequence-specific double-stranded DNA binding | 5 | HES6, HMBOX1, NEUROG1, NFATC1, NHLH2 |
| transcription regulator complex | 5 | HES6, MED7, NCOA2, NFATC1, NHLH2 |
|  DNA-binding transcription factor activity | 4 | FZD2, NEUROG1, NHLH2, TP53BP1 |
| single-stranded DNA binding | 4 | ERCC1, ERCC4, RAD18, RAD51B |
| DNA repair | 4 | ERCC1, ERCC4, RAD18, RAD51B |
| double-strand break repair via nonhomologous end joining | 4 | ERCC1, DCLRE1B, ERCC4, TP53BP1 |
| negative regulation of telomere maintenance | 4 | ERCC1, ERCC4, TERF2, TERF2IP |
|  transcription initiation by RNA polymerase II | 4 | ERCC1, MED11, MED19, MED7 |
| protection from non-homologous end joining at telomere | 4 | ACD, DCLRE1B, TERF2, TERF2IP |
| protein localization to chromosome, telomeric region | 4 | ACD, TERF2, TERF2IP, TINF2 |
| nuclear telomere cap complex | 4 | ACD, TERF2, TERF2IP, TINF2 |
| shelterin complex | 4 | ACD, TERF2, TERF2IP, TINF2 |
| kinetochore | 4 | CENPT, GTF2B, TP53BP1, ZWINT |
| RNA binding | 4 | CNOT7, DHX35, NOP10, NUFIP2 |
|  cell population proliferation | 4 | CNOT7, FGF2, RAD51B, TSC22D1 |
| negative regulation of DNA-templated transcription | 4 | CNOT7, HMBOX1, PML, UIMC1 |
| ATP binding | 4 | DHX35, PMS1, RAD51B, STK4 |
| signal transduction | 4 | DPYSL5, FGF2, SH3BP5, STK4 |
| nervous system development | 4 | DPYSL5, FGF2, HES6, NEUROG1 |
| transcription coregulator activity | 4 | GON4L, MED11, MED19, TP53BP1 |
| RNA polymerase II preinitiation complex assembly | 4 | GTF2B, MED11, MED19, MED7 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4 | HES6, NCOA2, NFATC1, NHLH2 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 4 | HES6, NEUROG1, NFATC1, NHLH2 |
|  transcription elongation by RNA polymerase II | 4 | INTS7, MED11, MED19, MED7 |
| ubiquitin protein ligase activity | 4 | MED11, MED7, RAD18, RNF2 |
| canonical Wnt signaling pathway | 3 | FZD2, FGF2, STK4 |
| promoter-specific chromatin binding | 3 | ERCC1, ERCC4, GTF2B |
| chromatin organization | 3 | ABRAXAS1, CBX1, UIMC1 |
| telomere maintenance via telomerase | 3 | ACD, NOP10, TERF2IP |
| negative regulation of telomere maintenance via telomerase | 3 | ACD, TERF2, TINF2 |
|  telomere maintenance via telomerase | 3 | ACD, HMBOX1, TERF2 |
| extracellular exosome | 3 | C11orf54, RP2, SH3BGRL3 |
| enzyme binding | 3 | CBX1, PMS1, TERF2 |
| DNA damage response | 3 | CBX1, RAD18, TP53BP1 |
| chromosome, centromeric region | 3 | CBX1, CENPB, CENPT |
| chromosome | 3 | CENPB, GTF2B, INTS7 |
| metal ion binding | 3 | CNOT7, RAD18, UIMC1 |
| negative regulation of gene expression | 3 | CNOT7, FGF2, TERF2 |
| centrosome | 3 | DCLRE1B, HMBOX1, RAD18 |
| protein-containing complex | 3 | DPYSL5, NCOA2, STK4 |
| transcription by RNA polymerase II | 3 | FGF2, GTF2B, TSC22D1 |
| DNA-binding transcription factor activity | 3 | HES6, NEUROG1, NFATC1 |
| protein dimerization activity | 3 | HES6, NCOA2, NHLH2 |
| protein ubiquitination | 3 | LRRC41, MED11, MED7 |
| mitochondrion | 3 | LYRM4, NBR1, SH3BP5 |
| ubiquitin ligase complex | 3 | MED11, MED7, RNF2 |
| mediator complex | 3 | MED11, MED19, MED7 |
| core mediator complex | 3 | MED11, MED19, MED7 |
| intracellular signal transduction | 3 | NFATC1, SH3BP5, STK4 |
| replication fork | 3 | RAD18, RAD51B, TP53BP1 |
| site of double-strand break | 3 | RAD18, TP53BP1, UIMC1 |
| cochlea morphogenesis | 2 | FZD2, NEUROG1 |
| plasma membrane | 2 | FZD2, RP2 |
| single-stranded DNA endodeoxyribonuclease activity | 2 | ERCC1, ERCC4 |
| TFIID-class transcription factor complex binding | 2 | ERCC1, ERCC4 |
| 3' overhang single-stranded DNA endodeoxyribonuclease activity | 2 | ERCC1, ERCC4 |
| nucleotide-excision repair | 2 | ERCC1, ERCC4 |
| male gonad development | 2 | ERCC1, NHLH2 |
| UV protection | 2 | ERCC1, ERCC4 |
| interstrand cross-link repair | 2 | ERCC1, DCLRE1B |
| telomeric DNA-containing double minutes formation | 2 | ERCC1, ERCC4 |
| negative regulation of protection from non-homologous end joining at telomere | 2 | ERCC1, ERCC4 |
| nucleotide-excision repair complex | 2 | ERCC1, ERCC4 |
| nucleotide-excision repair factor 1 complex | 2 | ERCC1, ERCC4 |
| ERCC4-ERCC1 complex | 2 | ERCC1, ERCC4 |
| polyubiquitin modification-dependent protein binding | 2 | ABRAXAS1, RAD18 |
|  DNA repair | 2 | ABRAXAS1, UIMC1 |
| double-strand break repair | 2 | ABRAXAS1, UIMC1 |
| mitotic G2 DNA damage checkpoint signaling | 2 | ABRAXAS1, UIMC1 |
| response to ionizing radiation | 2 | ABRAXAS1, UIMC1 |
| mitotic G2/M transition checkpoint | 2 | ABRAXAS1, UIMC1 |
| histone H2A K63-linked deubiquitination | 2 | ABRAXAS1, UIMC1 |
| BRCA1-A complex | 2 | ABRAXAS1, UIMC1 |
| telomere assembly | 2 | ACD, TINF2 |
|  telomerase activity | 2 | ACD, HMBOX1 |
| telomerase holoenzyme complex | 2 | ACD, NOP10 |
| methylated histone binding | 2 | CBX1, TP53BP1 |
| heterochromatin | 2 | CBX1, PML |
| pericentric heterochromatin | 2 | CBX1, CENPB |
| intracellular membrane-bounded organelle | 2 | CBX1, NBR1 |
| sequence-specific DNA binding | 2 | CENPB, HMBOX1 |
| mitotic cell cycle | 2 | CENPT, RNF2 |
| cell division | 2 | CENPT, ZWINT |
| DNA-binding transcription factor binding | 2 | CNOT7, GTF2B |
| negative regulation of cell population proliferation | 2 | CNOT7, PML |
| telomere maintenance via telomere lengthening | 2 | DCLRE1B, TERF2IP |
| telomeric loop formation | 2 | DCLRE1B, TERF2 |
| ATP hydrolysis activity | 2 | DHX35, PMS1 |
| mRNA splicing, via spliceosome | 2 | DHX35, PPWD1 |
| in utero embryonic development | 2 | DHX35, TERF2 |
| catalytic step 2 spliceosome | 2 | DHX35, PPWD1 |
| dendrite | 2 | DPYSL5, ZWINT |
| GTP binding | 2 | EEFSEC, RP2 |
| double-strand break repair via homologous recombination | 2 | ERCC4, RAD51B |
| response to UV | 2 | ERCC4, PML |
| negative regulation of telomere maintenance via telomere lengthening | 2 | ERCC4, TERF2 |
| nuclear receptor coactivator activity | 2 | FGF2, NCOA2 |
|  protein phosphorylation | 2 | FGF2, STK4 |
|  gene expression | 2 | FGF2, TERF2 |
| cell differentiation | 2 | FGF2, HES6 |
|  MAPK cascade | 2 | FGF2, STK4 |
| DNA-templated transcription | 2 | GON4L, TP53BP1 |
| chromatin remodeling | 2 | GTF2B, RNF2 |
| transcription initiation at RNA polymerase II promoter | 2 | GTF2B, MED7 |
| RNA polymerase II transcription regulator complex | 2 | GTF2B, NCOA2 |
| negative regulation of DNA-binding transcription factor activity | 2 | HES6, RNF2 |
| double-stranded telomeric DNA binding | 2 | HMBOX1, TERF2 |
| PML body | 2 | HMBOX1, PML |
| DNA damage checkpoint signaling | 2 | INTS7, TP53BP1 |
| transcription factor binding | 2 | MED19, NFATC1 |
| transcription coactivator activity | 2 | MED7, NCOA2 |
| circadian regulation of gene expression | 2 | NCOA2, PML |
| nucleic acid binding | 2 | NEUROG1, NFATC1 |
| cell fate commitment | 2 | NEUROG1, PML |
| DNA-binding transcription activator activity, RNA polymerase II-specific | 2 | NFATC1, NHLH2 |
| apoptotic process | 2 | NHLH2, STK4 |
| central nervous system development | 2 | NHLH2, STK4 |
| ubiquitin protein ligase binding | 2 | PML, RAD18 |
| protein import into nucleus | 2 | PML, STK4 |
| cellular senescence | 2 | PML, TERF2 |
| nucleolus | 2 | PML, TSEN54 |
| nuclear matrix | 2 | PML, TINF2 |
| ATP-dependent DNA damage sensor activity | 2 | PMS1, RAD51B |
| magnesium ion binding | 2 | RP2, STK4 |
| guanyl-nucleotide exchange factor activity | 2 | SBF1, SH3BP5 |
| negative regulation of epithelial cell proliferation | 2 | STK4, TINF2 |
| G-rich strand telomeric DNA binding | 2 | TERF2, TERF2IP |
| male germ cell nucleus | 2 | TERF2, TERF2IP |
| histone binding | 2 | TP53BP1, UIMC1 |
| ubiquitin modification-dependent histone binding | 2 | TP53BP1, UIMC1 |

